Methylphenidate vs placebo
Adverse events · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for apathy in Alzheimer's disease 2018 · Cochrane Headline outcomes onlyRR 1.28 [0.67, 2.42]3 studies · 145 participantsLow